Amsterdam-based healthcare venture builder and early-stage investor that turns university, hospital and corporate innovations into healthtech companies in Europe and the US.
NLC Health Ventures is a healthcare venture builder and early-stage healthtech investor founded in 2014 and headquartered in Amsterdam. The firm sources innovations from universities, academic hospitals and corporations, selects the most promising ones, and builds them into market-ready healthcare companies intended to reach patients. Its stated aim is to shorten the route from laboratory discovery to clinical use.
The company operates a healthcare venture building platform that systematically identifies and develops new ventures, producing approximately 25 new companies a year. More than 100 ventures have been built across Europe and the United States. Alongside the platform, the NLC Health Impact Fund invests in ongoing venture creation, aiming to bridge the gap between scientific innovation and real-world patient impact. Core technical domains include healthtech, healthcare innovation commercialisation, venture building and early-stage investing.
NLC Health Ventures employs a team of more than 40 experts who share resources and expertise across ventures, working to a mission of bringing healthcare innovations to market at scale. The firm maintains operations in Europe and the United States, with its headquarters in Amsterdam. Further information is available at https://nlc.health/.
